A STUDY OF MAGNESIUM SUPPLEMENTATION ON FASTING BLOOD GLUCOSE IN PATIENTS OF DIABETES MELLITUS TYPE-2

The study was done in 60 diabetic patients. These patients were divided into two groups, Group I (n=30) receiving Magnesium and Metformin therapy for a period of 16 weeks and Group II (n=30) receiving only Metformin therapy. The blood samples were collected and analyzed for Serum Magnesium and fasting blood glucose at 0, 4, 8, 16 weeks respectively. In GROUP I Mean Baseline value for S. Magnesium is 1.79±0.032 and after treatment values at 16 weeks 1.92±0.034. In this group we observed that S. Magnesium values before and after 16 weeks of magnesium supplementation was highly significant. In GROUP II Mean Baseline value for S. Magnesium is 1.79±0.031 and after treatment values at 16 weeks is 1.82±0.030. In this group there was no significant difference in S. Magnesium between before and after 16 weeks of treatment. In our study values for Mean fasting blood glucose level in group I before treatment (i.e. first visit) was 146.33±1.60 mg/dl as compared to 127.07±0.96 mg/dl values of after treatment. This difference was considered highly Significant between before and after treatment values for fasting blood glucose levels (p<0.001)In group II values for mean fasting blood glucose level before treatment (i.e. first visit) was 145.5±1.81 mg/dl as compared to 136.53±1.31 mg/dl values of fasting blood glucose after treatment. This Difference was also considered Significant.